A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer.

Molecules and cells

Volumn 34, Issue 6, 2012, Pages 523-529

  Oh, Young Mi ^a   Song, Yun Jeong ^b   Lee, Saet Byoul ^b   Jeong, Yunju ^b   Kim, Bogyou ^b   Kim, Geun Woong ^b   Kim, Kyung Eun ^b   Lee, Ji Min ^b   Cho, Mi Young ^b   Choi, Jaehyun ^b   Nam, Do Hyun ^b   Song, Paul H ^b   Cheong, Kwang Ho ^b   Kim, Kyung Ah ^b  

^a Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTI C ANTIBODY; ANTI-C ANTIBODY; MONOCLONAL ANTIBODY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL PROLIFERATION; HEPATOCYTE GROWTH FACTOR; HUMANS; ISOANTIBODIES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-MET; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85027925106     PISSN: None     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0194-z     Document Type: Article

References (0)